ID
14798
Description
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor; ODM derived from: https://clinicaltrials.gov/show/NCT00754325
Link
https://clinicaltrials.gov/show/NCT00754325
Keywords
Versions (1)
- 4/28/16 4/28/16 -
Uploaded on
April 28, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Breast Cancer NCT00754325
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnant or breast feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Description
chemotherapy regimen
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
Description
pleural or pericardial effusion
Data type
boolean
Alias
- UMLS CUI [1]
- C0032227
- UMLS CUI [2]
- C0031039
Description
cardiac condition
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Similar models
Eligibility Advanced Breast Cancer NCT00754325
- StudyEvent: Eligibility
C0232970 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0031039 (UMLS CUI [2])